Join to View Full Profile
345 23rd Ave NNashville, TN 37203
Phone+1 615-983-6000
Fax+1 615-983-6010
Dr. Reichstein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Icahn School of Medicine at Mount SinaiClass of 2006
Certifications & Licensure
KY State Medical License 2014 - 2026
TN State Medical License 2014 - 2025
WI State Medical License 2012 - 2015
PA State Medical License 2009 - 2014
American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- 1 citationsAflibercept Biosimilar MYL-1701P vs Reference Aflibercept in Diabetic Macular Edema: The INSIGHT Randomized Clinical Trial.Susan B Bressler, Abhijit Barve, Prasanna C Ganapathi, Katrin Beckmann, Rajendra S Apte
JAMA Ophthalmology. 2024-10-01 - 7 citations15-Gene Expression Profile andas Integrated Prognostic Test for Uveal Melanoma: First Report of Collaborative Ocular Oncology Group Study No. 2 (COOG2.1).J William Harbour, Zelia M Correa, Amy C Schefler, Prithvi Mruthyunjaya, Miguel A Materin
Journal of Clinical Oncology. 2024-10-01 - 1 citationsSUSTAINED BIWEEKLY AFLIBERCEPT FOR REFRACTORY NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: The Prospective TRISTAR Study.Eric W Schneider, Mridul K Thomas, Franco M Recchia, David A Reichstein, Carl C Awh
Retina. 2023-05-01
Press Mentions
Eye Physics (EP) Plaques for Uveal Melanoma: Initial 12- and 24-Month Results in a Private Practice Setting Performed by a Young SurgeonJuly 26th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
